Alfuzosin Hydrochloride
Overview
Alfuzosin Hydrochloride is an alpha-1 adrenergic receptor antagonist used primarily to treat benign prostatic hyperplasia (BPH). It works by relaxing muscles in the prostate and bladder neck, making it easier to urinate.
API suppliers (13)
Suppliers of Alfuzosin Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 9 of 13 suppliers.
5 of 13 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- SANOFI CHIMIEFrance1 active DMF
- Wockhardt UsaUnited Kingdom1 active DMF
- Cipla USA, Inc.USA
- FARMAK ASUkraine
- STANDARD CHEM AND PHARM CO LTD
- DR REDDYS LABORATORIES LTD GMP on record
- Shandong New Time Pharmaceutical Co Ltd GMP on record
- Cadila Healthcare LimitedIndia
- Joint Stock Company FarmakUkraineCEP
- LUNDBECK PHARMACEUTICALS ITALY SPAItaly GMP on record
- FINORGA GMP on record
- EXCELLA GMBH AND CO KGGermany
EU CEP holders (5)
Companies holding a valid EU Certificate of Suitability (CEP) for Alfuzosin Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Alfuzosin Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.